Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study.

Identifieur interne : 000089 ( PubMed/Curation ); précédent : 000088; suivant : 000090

Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study.

Auteurs : Kenji Kuroda [Japon] ; Yasuhiro Yamamoto [Japon] ; Manami Yanagisawa [Japon] ; Akira Kawata [Japon] ; Naoya Akiba [Japon] ; Kensuke Suzuki [Japon] ; Kazutoshi Naritaka [Japon]

Source :

RBID : pubmed:28743274

Descripteurs français

English descriptors

Abstract

Lower limb lymphedema (LLL) is a chronic and incapacitating condition afflicting patients who undergo lymphadenectomy for gynecologic cancer. This study aimed to identify risk factors for LLL and to develop a prediction model for its occurrence.

DOI: 10.1186/s12905-017-0403-1
PubMed: 28743274

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:28743274

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study.</title>
<author>
<name sortKey="Kuroda, Kenji" sort="Kuroda, Kenji" uniqKey="Kuroda K" first="Kenji" last="Kuroda">Kenji Kuroda</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan. kenji.kuroda@hospital.yaizu.shizuoka.jp.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Yamamoto, Yasuhiro" sort="Yamamoto, Yasuhiro" uniqKey="Yamamoto Y" first="Yasuhiro" last="Yamamoto">Yasuhiro Yamamoto</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Yanagisawa, Manami" sort="Yanagisawa, Manami" uniqKey="Yanagisawa M" first="Manami" last="Yanagisawa">Manami Yanagisawa</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kawata, Akira" sort="Kawata, Akira" uniqKey="Kawata A" first="Akira" last="Kawata">Akira Kawata</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Akiba, Naoya" sort="Akiba, Naoya" uniqKey="Akiba N" first="Naoya" last="Akiba">Naoya Akiba</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Suzuki, Kensuke" sort="Suzuki, Kensuke" uniqKey="Suzuki K" first="Kensuke" last="Suzuki">Kensuke Suzuki</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Naritaka, Kazutoshi" sort="Naritaka, Kazutoshi" uniqKey="Naritaka K" first="Kazutoshi" last="Naritaka">Kazutoshi Naritaka</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28743274</idno>
<idno type="pmid">28743274</idno>
<idno type="doi">10.1186/s12905-017-0403-1</idno>
<idno type="wicri:Area/PubMed/Corpus">000089</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000089</idno>
<idno type="wicri:Area/PubMed/Curation">000089</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000089</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study.</title>
<author>
<name sortKey="Kuroda, Kenji" sort="Kuroda, Kenji" uniqKey="Kuroda K" first="Kenji" last="Kuroda">Kenji Kuroda</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan. kenji.kuroda@hospital.yaizu.shizuoka.jp.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Yamamoto, Yasuhiro" sort="Yamamoto, Yasuhiro" uniqKey="Yamamoto Y" first="Yasuhiro" last="Yamamoto">Yasuhiro Yamamoto</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Yanagisawa, Manami" sort="Yanagisawa, Manami" uniqKey="Yanagisawa M" first="Manami" last="Yanagisawa">Manami Yanagisawa</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kawata, Akira" sort="Kawata, Akira" uniqKey="Kawata A" first="Akira" last="Kawata">Akira Kawata</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Akiba, Naoya" sort="Akiba, Naoya" uniqKey="Akiba N" first="Naoya" last="Akiba">Naoya Akiba</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Suzuki, Kensuke" sort="Suzuki, Kensuke" uniqKey="Suzuki K" first="Kensuke" last="Suzuki">Kensuke Suzuki</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Naritaka, Kazutoshi" sort="Naritaka, Kazutoshi" uniqKey="Naritaka K" first="Kazutoshi" last="Naritaka">Kazutoshi Naritaka</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">BMC women's health</title>
<idno type="eISSN">1472-6874</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Area Under Curve</term>
<term>Female</term>
<term>Genital Neoplasms, Female (pathology)</term>
<term>Genital Neoplasms, Female (surgery)</term>
<term>Hospitals (statistics & numerical data)</term>
<term>Humans</term>
<term>Incidence</term>
<term>Kaplan-Meier Estimate</term>
<term>Lower Extremity (pathology)</term>
<term>Lymph Node Excision (adverse effects)</term>
<term>Lymph Node Excision (methods)</term>
<term>Lymph Nodes (pathology)</term>
<term>Lymphedema (epidemiology)</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (pathology)</term>
<term>Middle Aged</term>
<term>Models, Theoretical</term>
<term>Postoperative Complications (etiology)</term>
<term>Prevalence</term>
<term>Proportional Hazards Models</term>
<term>Retrospective Studies</term>
<term>Risk Assessment (methods)</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Aire sous la courbe</term>
<term>Complications postopératoires (étiologie)</term>
<term>Estimation de Kaplan-Meier</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hôpitaux ()</term>
<term>Incidence</term>
<term>Lymphadénectomie ()</term>
<term>Lymphadénectomie (effets indésirables)</term>
<term>Lymphoedème (anatomopathologie)</term>
<term>Lymphoedème (épidémiologie)</term>
<term>Lymphoedème (étiologie)</term>
<term>Membre inférieur (anatomopathologie)</term>
<term>Modèles de hasards proportionnels</term>
<term>Modèles théoriques</term>
<term>Noeuds lymphatiques (anatomopathologie)</term>
<term>Prévalence</term>
<term>Sujet âgé</term>
<term>Tumeurs de l'appareil génital féminin ()</term>
<term>Tumeurs de l'appareil génital féminin (anatomopathologie)</term>
<term>Études rétrospectives</term>
<term>Évaluation des risques ()</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Lymph Node Excision</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Lymphoedème</term>
<term>Membre inférieur</term>
<term>Noeuds lymphatiques</term>
<term>Tumeurs de l'appareil génital féminin</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Lymphadénectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Lymphedema</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Lymph Node Excision</term>
<term>Risk Assessment</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Genital Neoplasms, Female</term>
<term>Lower Extremity</term>
<term>Lymph Nodes</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en">
<term>Hospitals</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Genital Neoplasms, Female</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Complications postopératoires</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Area Under Curve</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Kaplan-Meier Estimate</term>
<term>Middle Aged</term>
<term>Models, Theoretical</term>
<term>Prevalence</term>
<term>Proportional Hazards Models</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Aire sous la courbe</term>
<term>Estimation de Kaplan-Meier</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hôpitaux</term>
<term>Incidence</term>
<term>Lymphadénectomie</term>
<term>Modèles de hasards proportionnels</term>
<term>Modèles théoriques</term>
<term>Prévalence</term>
<term>Sujet âgé</term>
<term>Tumeurs de l'appareil génital féminin</term>
<term>Études rétrospectives</term>
<term>Évaluation des risques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Lower limb lymphedema (LLL) is a chronic and incapacitating condition afflicting patients who undergo lymphadenectomy for gynecologic cancer. This study aimed to identify risk factors for LLL and to develop a prediction model for its occurrence.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">28743274</PMID>
<DateCreated>
<Year>2017</Year>
<Month>07</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>2017</Year>
<Month>08</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>08</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1472-6874</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>17</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2017</Year>
<Month>Jul</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>BMC women's health</Title>
<ISOAbbreviation>BMC Womens Health</ISOAbbreviation>
</Journal>
<ArticleTitle>Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study.</ArticleTitle>
<Pagination>
<MedlinePgn>50</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12905-017-0403-1</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lower limb lymphedema (LLL) is a chronic and incapacitating condition afflicting patients who undergo lymphadenectomy for gynecologic cancer. This study aimed to identify risk factors for LLL and to develop a prediction model for its occurrence.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Pelvic lymphadenectomy (PLA) with or without para-aortic lymphadenectomy (PALA) was performed on 366 patients with gynecologic malignancies at Yaizu City Hospital between April 2002 and July 2014; we retrospectively analyzed 264 eligible patients. The intervals between surgery and diagnosis of LLL were calculated; the prevalence and risk factors were evaluated using the Kaplan-Meier and Cox proportional hazards methods. We developed a prediction model with which patients were scored and classified as low-risk or high-risk.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The cumulative incidence of LLL was 23.1% at 1 year, 32.8% at 3 years, and 47.7% at 10 years post-surgery. LLL developed after a median 13.5 months. Using regression analysis, body mass index (BMI) ≥25 kg/m(2) (hazard ratio [HR], 1.616; 95% confidence interval [CI], 1.030-2.535), PLA + PALA (HR, 2.323; 95% CI, 1.126-4.794), postoperative radiation therapy (HR, 2.469; 95% CI, 1.148-5.310), and lymphocyst formation (HR, 1.718; 95% CI, 1.120-2.635) were found to be independently associated with LLL; age, type of cancer, number of lymph nodes, retroperitoneal suture, chemotherapy, lymph node metastasis, herbal medicine, self-management education, or infection were not associated with LLL. The predictive score was based on the 4 associated variables; patients were classified as high-risk (scores 3-6) and low-risk (scores 0-2). LLL incidence was significantly greater in the high-risk group than in the low-risk group (HR, 2.19; 95% CI, 1.440-3.324). The cumulative incidence at 5 years was 52.1% [95% CI, 42.9-62.1%] for the high-risk group and 28.9% [95% CI, 21.1-38.7%] for the low-risk group. The area under the receiver operator characteristics curve for the prediction model was 0.631 at 1 year, 0.632 at 3 years, 0.640 at 5 years, and 0.637 at 10 years.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">BMI ≥25 kg/m(2), PLA + PALA, lymphocyst formation, and postoperative radiation therapy are significant predictive factors for LLL. Our prediction model may be useful for identifying patients at risk of LLL following lymphadenectomy. Providing an intensive therapeutic strategy for high-risk patients may help reduce the incidence of LLL and conserve the quality of life.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kuroda</LastName>
<ForeName>Kenji</ForeName>
<Initials>K</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-9960-9673</Identifier>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan. kenji.kuroda@hospital.yaizu.shizuoka.jp.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yamamoto</LastName>
<ForeName>Yasuhiro</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yanagisawa</LastName>
<ForeName>Manami</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kawata</LastName>
<ForeName>Akira</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Akiba</LastName>
<ForeName>Naoya</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Suzuki</LastName>
<ForeName>Kensuke</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Naritaka</LastName>
<ForeName>Kazutoshi</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Yaizu City Hospital, 1000, Dobara, Yaizu-shi, 425-8505, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2017</Year>
<Month>07</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMC Womens Health</MedlineTA>
<NlmUniqueID>101088690</NlmUniqueID>
<ISSNLinking>1472-6874</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2015 Mar 1;136(5):E359-86</RefSource>
<PMID Version="1">25220842</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gynecol Oncol. 2011 May 1;121(2):347-52</RefSource>
<PMID Version="1">21324517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2012 Oct 20;30(30):3726-33</RefSource>
<PMID Version="1">23008299</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2011;9(2):93-9</RefSource>
<PMID Version="1">21688978</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Expert Rev Pharmacoecon Outcomes Res. 2011 Jun;11(3):287-97</RefSource>
<PMID Version="1">21671698</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Gynecol Cancer. 2012 May;22(4):686-91</RefSource>
<PMID Version="1">22398707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gynecol Oncol. 2017 Jan;144(1):153-158</RefSource>
<PMID Version="1">28094037</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Support Care Cancer. 2011 Jun;19(6):853-7</RefSource>
<PMID Version="1">21240649</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Breast J. 2010 Jan-Feb;16(1):48-54</RefSource>
<PMID Version="1">19889169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphology. 2013 Mar;46(1):1-11</RefSource>
<PMID Version="1">23930436</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Clin Oncol. 2016 Aug;21(4):741-7</RefSource>
<PMID Version="1">26857458</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Surg Oncol. 2012 Aug;19(8):2580-9</RefSource>
<PMID Version="1">22395997</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer. 2011 Mar 1;117(5):948-56</RefSource>
<PMID Version="1">20945318</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Gynecol Cancer. 2015 May;25(4):751-7</RefSource>
<PMID Version="1">25723779</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Gynecol Cancer. 2006 May-Jun;16(3):1130-9</RefSource>
<PMID Version="1">16803496</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gynecol Oncol. 2012 Jul;126(1):93-8</RefSource>
<PMID Version="1">22516659</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMJ. 2010 Jan 12;340:b5396</RefSource>
<PMID Version="1">20068255</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Obstet Gynecol. 1999 Sep;94(3):391-4</RefSource>
<PMID Version="1">10472865</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PM R. 2012 Aug;4(8):580-601</RefSource>
<PMID Version="1">22920313</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Gynaecol Oncol. 2013;34(1):23-7</RefSource>
<PMID Version="1">23589994</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Obstet Gynecol Reprod Biol. 2013 Oct;170(2):539-43</RefSource>
<PMID Version="1">23932376</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gynecol Oncol. 2014 May;133(2):274-7</RefSource>
<PMID Version="1">24582865</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Gynecol Cancer. 2015 Mar;25(3):521-5</RefSource>
<PMID Version="1">25621410</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2014 Jun;12(2):103-9</RefSource>
<PMID Version="1">24927065</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gynecol Oncol. 2015 Jan;136(1):87-93</RefSource>
<PMID Version="1">25448454</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Rehabil Med. 2011 Oct;35(5):687-93</RefSource>
<PMID Version="1">22506192</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gynecol Oncol. 2010 Oct;119(1):60-4</RefSource>
<PMID Version="1">20638109</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2012 May 31;366(22):2136-7</RefSource>
<PMID Version="1">22646649</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cochrane Database Syst Rev. 2016 Nov 22;11:CD005342</RefSource>
<PMID Version="1">27873308</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Natl Compr Canc Netw. 2015 Apr;13(4):395-404; quiz 404</RefSource>
<PMID Version="1">25870376</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 2010 Dec 22;304(24):2699-705</RefSource>
<PMID Version="1">21148134</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Surg Oncol. 2013 Jan;39(1):81-6</RefSource>
<PMID Version="1">23117018</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Clin Oncol. 2011 Jun;16(3):238-43</RefSource>
<PMID Version="1">21213009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Angiogenesis. 2014 Apr;17(2):325-34</RefSource>
<PMID Version="1">24449090</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Support Care Cancer. 2011 May;19(5):703-10</RefSource>
<PMID Version="1">20467755</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bone Marrow Transplant. 2013 Mar;48(3):452-8</RefSource>
<PMID Version="1">23208313</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Natl Compr Canc Netw. 2014 Feb;12(2):248-80</RefSource>
<PMID Version="1">24586086</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Evid Based Complement Alternat Med. 2013;2013:241629</RefSource>
<PMID Version="1">23861700</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Oncol. 2011 May;12 (5):469-76</RefSource>
<PMID Version="1">21489874</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Obstet Gynaecol Res. 2015 Sep;41(9):1449-56</RefSource>
<PMID Version="1">26013736</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gynecol Oncol. 2014 Apr;133(1):23-7</RefSource>
<PMID Version="1">24680587</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2010 Sep 10;28(26):4074-80</RefSource>
<PMID Version="1">20644095</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Natl Compr Canc Netw. 2013 Oct 1;11(10):1199-209</RefSource>
<PMID Version="1">24142821</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Surg Oncol. 2012 Jan;19(1):268-73</RefSource>
<PMID Version="1">21717243</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Heart Circ Physiol. 2015 May 1;308(9):H1065-77</RefSource>
<PMID Version="1">25724493</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Obstet Gynecol Reprod Biol. 2012 Apr;161(2):125-9</RefSource>
<PMID Version="1">22364898</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):498-503</RefSource>
<PMID Version="1">23541809</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>World J Surg Oncol. 2013 Sep 22;11:237</RefSource>
<PMID Version="1">24053624</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Gynecol Cancer. 2011 Feb;21(2):409-18</RefSource>
<PMID Version="1">21270623</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Plast Reconstr Aesthet Surg. 2016 Mar;69(3):368-75</RefSource>
<PMID Version="1">26644082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Support Care Cancer. 2016 Mar;24(3):1413-9</RefSource>
<PMID Version="1">26349574</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005833" MajorTopicYN="N">Genital Neoplasms, Female</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Body mass index</Keyword>
<Keyword MajorTopicYN="N">Lower limb lymphedema</Keyword>
<Keyword MajorTopicYN="N">Lymph node dissection</Keyword>
<Keyword MajorTopicYN="N">Lymphocyst</Keyword>
<Keyword MajorTopicYN="N">Prediction model</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>05</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>07</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>7</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>7</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>8</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28743274</ArticleId>
<ArticleId IdType="doi">10.1186/s12905-017-0403-1</ArticleId>
<ArticleId IdType="pii">10.1186/s12905-017-0403-1</ArticleId>
<ArticleId IdType="pmc">PMC5526302</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000089 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000089 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:28743274
   |texte=   Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:28743274" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024